Navigation Links
LCA-Vision Announces CEO Resignation
Date:9/18/2009

CINCINNATI, Sept. 18 /PRNewswire-FirstCall/ -- LCA-Vision Inc. (Nasdaq: LCAV), a leading provider of laser vision correction services under the LasikPlus(R) brand, announces that Steven C. Straus has resigned as Chief Executive Officer and a member of the company's board of directors effective September 25, 2009 to lead another healthcare company outside of the ophthalmology industry. Management of daily operations will be the responsibility of Chief Operating Officer David L. Thomas and Chief Financial Officer Michael Celebrezze, jointly reporting to the board of directors through non-Executive Chairman E. Anthony Woods.

"On behalf of the LCA-Vision board of directors, our surgeons and all employees, I would like to thank Steve for his service to our company and wish him well in his new endeavor," said Mr. Woods. "We are fortunate to have an excellent team in place companywide, and I am confident that our executives have the skills to advance our business plan and guide LCA-Vision through current macroeconomic challenges.

"The employees of LCA-Vision are fully committed to achieving success in the marketplace and, in turn, creating long-term sustainable shareholder value," he added. "Our strategic and operating plan continues to be built upon excellence in service and clinical outcomes, prudent expense management, innovative and effective marketing, advanced technology and an expanded and strengthened business model."

About LCA-Vision Inc./LasikPlus(R)

LCA-Vision Inc., a leading provider of laser vision correction services under the LasikPlus(R) brand, operates 71 LasikPlus(R) fixed-site laser vision correction centers in 31 states and 53 markets in the United States and a joint venture in Canada. Additional company information is available at www.lca-vision.com and www.lasikplus.com.

           Earning Trust Every Moment to Forge Lifetime Relationships.

    For Additional Information

    Company Contact:                Investor Relations Contact:
    Barb Kise                       Jody Cain
    LCA-Vision Inc.                 Lippert/Heilshorn & Associates
    513-792-9292                    310-691-7100


'/>"/>
SOURCE LCA-Vision Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. LCA-Vision Names Michael J. Celebrezze CFO
2. Shareholder Class Action Filed Against LCA-Vision, Inc. by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
3. Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers
4. Rigel Announces Pricing of Public Offering of 13,000,000 Shares of Common Stock
5. InterMune Announces Collaboration With National Jewish Health on NIH-Supported Genetic Research in Idiopathic Pulmonary Fibrosis
6. Aethlon Medical, Inc. Announces Annual Meeting Results
7. Sangamo BioSciences Announces Presentation at the UBS Global Life Sciences Conference
8. Martek Announces Addition to Its Board of Directors
9. Pervasis Therapeutics Announces $17 Million in Financing and New Board Member
10. BVGH Announces New Board Chair
11. Poniard Pharmaceuticals Announces Pivotal Phase 3 SPEAR Trial Evaluating Picoplatin in Small Cell Lung Cancer Reaches 320th Event Target
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Bay, Florida (PRWEB) , ... October 11, 2017 ... ... and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel ... (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the cell ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive global ... technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). Additionally, ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and ... San Diego Rotary Club. The event entitled “Stem Cells and Their ... 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
Breaking Biology Technology:
(Date:4/11/2017)... , April 11, 2017 NXT-ID, ... security technology company, announces the appointment of independent Directors Mr. ... to its Board of Directors, furthering the company,s corporate ... ... NXT-ID, we look forward to their guidance and benefiting from ...
(Date:4/4/2017)... YORK , April 4, 2017   EyeLock ... today announced that the United States Patent and Trademark ... patent broadly covers the linking of an iris image ... same transaction) and represents the company,s 45 th ... latest patent is very timely given the multi-modal biometric ...
(Date:3/29/2017)... the health IT company that operates the largest health ... today announced a Series B investment from BlueCross BlueShield ... investment and acquisition accelerates higi,s strategy to create the ... activities through the collection and workflow integration of ambient ... secures data today on behalf of over 36 million ...
Breaking Biology News(10 mins):